Skip to main content
. 2021 Dec 18;9(2):ofab589. doi: 10.1093/ofid/ofab589

Table 2.

Primary and Secondary Outcomes in Patients Receiving Dalbavancin and Standard of Care

Outcome Dalbavancin (n = 42) Standard of Care (n = 90) P Value
Treatment failure, No. (%) 9 (21.4) 21 (23.3) .808
Days to treatment failure, mean (SD) 134.3 (70.1) 95.3 (75.9) .169
Infection-related readmission, No. (%) 13 (31) 28 (31.1) .985
Hospital LOS, mean (SD), d 5.2 (4.2) 7.2 (4.4) .013

Abbreviation: LOS, length of stay.